Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

BCAB

BioAtla (BCAB)

BioAtla Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BCAB
DateHeureSourceTitreSymboleSociété
14/06/202422h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCABBioAtla Inc
13/06/202423h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCABBioAtla Inc
14/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCABBioAtla Inc
16/06/202300h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCABBioAtla Inc
14/06/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCABBioAtla Inc
11/05/202323h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCABBioAtla Inc
27/04/202318h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BCABBioAtla Inc
24/04/202323h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BCABBioAtla Inc
23/03/202322h17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BCABBioAtla Inc
23/03/202322h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCABBioAtla Inc
14/02/202322h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCABBioAtla Inc
06/02/202320h51Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NASDAQ:BCABBioAtla Inc
09/01/202323h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BCABBioAtla Inc
06/01/202322h21Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BCABBioAtla Inc
29/12/202222h05PR Newswire (US)Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of DirectorsNASDAQ:BCABBioAtla Inc
08/11/202206h35TipRanksJMP Securities Reaffirms Their Buy Rating on BioAtla (BCAB)NASDAQ:BCABBioAtla Inc
04/11/202211h36TipRanksBioAtla (BCAB) Receives a Buy from H.C. WainwrightNASDAQ:BCABBioAtla Inc
04/11/202210h55TipRanksBioAtla Pops After Encouraging Q3 ResultsNASDAQ:BCABBioAtla Inc
20/09/202223h54Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BCABBioAtla Inc
20/09/202223h51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:BCABBioAtla Inc
15/09/202206h35TipRanksBioAtla (BCAB) Receives a Buy from JMP SecuritiesNASDAQ:BCABBioAtla Inc
12/09/202216h08PR Newswire (US)Himalaya Therapeutics Announces Interim Phase 2 Results for Mecbotamab vedotin (HTBA3011)NASDAQ:BCABBioAtla Inc
10/08/202212h25TipRanksH.C. Wainwright Sticks to Its Buy Rating for BioAtla (BCAB)NASDAQ:BCABBioAtla Inc
17/05/202223h28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BCABBioAtla Inc
15/05/202215h20TipRanksBioAtla (BCAB) Receives a Buy from J.P. MorganNASDAQ:BCABBioAtla Inc
13/03/202213h35TipRanksJ.P. Morgan Thinks BioAtla’s Stock is Going to RecoverNASDAQ:BCABBioAtla Inc
01/03/202212h00PR Newswire (US)BIOATLA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTSNASDAQ:BCABBioAtla Inc
04/02/202215h17Edgar (US Regulatory)Schedule 13gNASDAQ:BCABBioAtla Inc
02/02/202223h49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCABBioAtla Inc
01/02/202216h19ValueWalkThese Are The Ten Worst Performing Small Cap Stocks In January 2022NASDAQ:BCABBioAtla Inc
 Showing the most relevant articles for your search:NASDAQ:BCAB